EMCDDA Technical Report on New Psychoactive Substance

Published by

The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid agonist that has recently emerged on the drug market in Europe, in order to support the risk assessment of the substance which has been requested by the European Commission.

Table of contents

  1. Summary
  2. Background
  3. Chemical and physical properties, methods and the precursors used for manufacture or extraction
  4. Legitimate use
  5. Pharmacological and toxicological properties
  6. Extent and patterns of use, availability, and potential for diffusion
  7. Health risks Social risks
  8. Other relevant information
  9. References